Drug factory · FDA FEI 3008205509

BCN Peptides Sa

POLIGONO INDUSTRIAL ELS VINYETS-FOGARS, CR. COMARCAL C-244 KM 22 SECTOR II, Sant Quinti De Mediona, Spain

Spain: 1

Problems found, fixed voluntarily at FDA's last inspection, Oct 9, 2023.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

5 drug inspections on record since 2010: 2 with no problems, 3 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
IcatibantMakes the active ingredient Cipla USA., Inc. 69097-664

FDA inspection history

EndedResultProgramProblems noted
Oct 9, 2023Problems found, fixed voluntarilyDrug Quality Assurance—
Mar 15, 2019Problems found, fixed voluntarilyDrug Quality Assurance—
Jan 16, 2015No problems foundDrug Quality Assurance—
Apr 26, 2012No problems foundDrug Quality Assurance—
Mar 18, 2010Problems found, fixed voluntarilyDrug Quality Assurance—

Registered with FDA for: api manufacture.